DPIIT recognised startup Government of India
Startup India
Cipher Oncology Private Limited - healthcare in Hyderabad, Telangana, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹9.86 Cr
▲ 65% YoY
Net loss · FY 2025
₹9.95 Cr
Net margin -101%
EBITDA · FY 2025
-₹9.67 Cr
EBITDA margin -98.1%
Authorised capital
₹4.25 Cr
Registered with MCA
Paid-up capital
₹3.27 Cr
Issued & subscribed
Company age
7 yrs
Est. 2019
Employees · EPFO
125
Provident fund records
Directors on board
2
As per MCA filings
About Cipher Oncology Private Limited
Data last updated:
Cipher Oncology Private Limited is a private limited company based in Hyderabad, Telangana, India, recognised as a startup by DPIIT. It operates in the oncology clinics and cancer treatment segment of the healthcare sector. It was incorporated on 30 April 2019 and has been in existence for over 7 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U85100TG2019PTC132422. Its GSTIN is 36AAICC1561H1ZR (Telangana). The company holds 2 GST registrations, all of them active.
The company has an authorised share capital of ₹4.25 Cr and a paid-up capital of ₹3.27 Cr. It is led by directors Sonali Pradeep Srungaram (Managing Director) and Sasi Kiran Sunkara.
Its last annual general meeting (AGM) was held on 25 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at I Park, Hyderabad, Telangana.
As per the financials filed for FY 2025, the company reported a revenue of ₹9.86 Cr, a growth of 65% compared to the previous year. For the same year it recorded a net loss of ₹9.95 Cr (net margin -101%) and EBITDA of -₹9.67 Cr (EBITDA margin -98.1%). Revenue has grown at a compounded annual rate (CAGR) of 47% over three years and 88% over five years.
The company has about 125 employees on its provident fund (EPFO) records.
The company is associated with 2 brands: CION Cancer Clinics and Cipher Healthcare. Court records list 2 cases involving the company, including 2 filed by the company. The company has 11 deals on record (7 funding rounds, 4 secondary share transfers), with disclosed funding of ₹94.43 Cr; the latest was in September 2025. Its 5 peer companies in the Healthcare industry (Oncology Care), with the same principal business activity (hospital activities) are compared by revenue, 3 larger and 2 smaller; the largest is Malnad Hospital and Institute of Oncology Private Limited with revenue of ₹11.66 Cr.
For more details, the company can be reached via its website cioncancerclinics.com.
Company details
CIN U85100TG2019PTC132422
Registration Number 132422
Incorporation Date 30 April 2019
ROC Hyderabad
Listing Status Unlisted
Company Status Active
DPIIT Recognition Recognised Startup
Recognitions & Rankings of Cipher Oncology
Contact details
Cipher Oncology Private Limited's registered office is in Hyderabad, Telangana. Its website is cioncancerclinics.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered AddressH.No.8 – 2 – 293/82/J – III/573 – I Park View Complex R No 1 Co – Operative Housing Society Jub, Ilee Hills, Hyderabad, Telangana, India – 500096
- IndustryHealthcare, Oncology Clinics & Cancer Treatment
To see the full contact details of Cipher Oncology Private Limited, buy the company report.
Comprehensive company report
Cipher Oncology Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Cipher Oncology operates two associated brands: CION Cancer Clinics and Cipher Healthcare. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Cancer treatments and support are provided by a clinic chain. | cioncancerclinics.com | |
| Cipher Healthcare is involved in healthcare design solutions. | cipherhealthcare.com |
Business activity
The main business activities of Cipher Oncology are hospital and medical care and trade. In detail, this covers hospital activities and retail trading. 2 activity segments are registered with the MCA.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| Q | Hospital and Medical Care | Q1 | Hospital activities | |
| G | Trade | G2 | Retail Trading |
To see the full business activity and turnover split of Cipher Oncology Private Limited, buy the company report.
Financials of Cipher Oncology Private Limited
FY 2025 filings availableCipher Oncology Private Limited reported revenue of ₹9.86 Cr (up 65% YoY) for FY 2025.
Revenue · FY 2025
₹9.86 Cr ▲ 65%
Net loss · FY 2025
₹9.95 Cr margin -101%
EBITDA · FY 2025
-₹9.67 Cr margin -98.1%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 65%
3 years · compounded
▲ 47%
5 years · compounded
▲ 88%
EBITDA CAGR growth
1 year
▼ 16%
3 years · compounded
▼ 30%
5 years · compounded
▼ 27%
Revenue has grown at a compounded annual rate (CAGR) of 88% over five years, including 65% growth in the latest year. EBITDA fell 16% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹9.67 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹9.95 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -98.1% | ||||
| Net Profit Margin | -101% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Cipher Oncology Private Limited, buy the company report.
Board of directors of Cipher Oncology Private Limited
Cipher Oncology has 2 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sasi Kiran Sunkara Also directs: Cipher Doctors LLP, Cipher Healthcare Private Limited | Director | 30 Apr 2019 | 7 Years 6 Months | Current |
| Sonali Pradeep Srungaram Also directs: Cipher Doctors LLP, Cipher Healthcare Private Limited | Managing Director | 30 Apr 2019 | 7 Years 6 Months | Current |
Peer comparison
Cipher Oncology Private Limited is compared with the 5 companies closest to it by revenue in the Healthcare industry (Oncology Care), with the same principal business activity (hospital activities), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Malnad Hospital and Institute of Oncology Private Limited | ₹11.66 Cr (FY 2025) | 12.0% | Shimoga, Karnataka, India | |||
| Kakatiya Institute of Oncology Private Limited | ₹10.53 Cr (FY 2025) | 1.0% | Hyderabad, Telangana, India | |||
| Karunadu Oncology Haematology Associates Private Limited | ₹10.39 Cr (FY 2025) | -1.0% | Hubli, Karnataka, India | |||
| Cipher Oncology Private Limitedthis company | ₹9.86 Cr (FY 2025) | -₹9.95 Cr | -101% | 65.0% | 125 | Hyderabad, Telangana, India |
| Erode Cancer Centre Private Limited | ₹9.73 Cr (FY 2025) | 3.0% | Erode, Tamil Nadu, India | |||
| Bridge Gap Lifesciences Private Limited | ₹9.29 Cr (FY 2024) | 9.0% | Hyderabad, Telangana, India |
To see the full peer comparison of Cipher Oncology Private Limited, buy the company report.
Auditor
Cipher Oncology Private Limited is audited by R. Subrahmanyam& Company for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| R. Subrahmanyam& Company | FY 2023 | 004102S |
Shareholding
The shareholding of Cipher Oncology Private Limited is on record for 4 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|
| Promoters | ||||
| Domestic institutional investors (DII) | ||||
| Foreign institutional investors (FII) | ||||
| Public | ||||
| Others |
To see the full shareholding pattern of Cipher Oncology Private Limited, buy the company report.
Deals & funding
Cipher Oncology Private Limited has 11 deals on record (7 funding rounds, 4 secondary share transfers), with disclosed funding of ₹94.43 Cr; the latest was in September 2025.
Total deals
11
Funding rounds
7
Secondary share transfers
4
Disclosed funding
₹94.43 Cr
Deals on record (5 of 11)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Sep 2025 | Funding round · Series A | ₹5.02 Cr | Investors: Aroa Venture Partners (ScaleX Partners), Murata Manufacturing Co Limited |
| Jun 2024 | Funding round | ₹6.1 Cr | Investors: Axilor, Natco Pharma Limited , 2 individuals |
| Mar 2024 | Secondary share transfer | Undisclosed | Buyer: Cipher Oncology Employee Welfare Trust Seller: Cipher Healthcare Private Limited |
| Aug 2021 | Secondary share transfer | Undisclosed | Buyer: Brand Capital Seller: Cipher Healthcare Private Limited |
| May 2019 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: Cipher Healthcare Private Limited |
To see the full deal history of Cipher Oncology Private Limited, buy the company report.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Cipher Oncology Private Limited has 2 court cases on record: 2 filed by Cipher Oncology. All cases are disposed.
Total cases
2
Filed by the company
2
Disposed
2
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 2 | 0 | 0 |
Cases on record (1 of 2)
| Court | Type of case | Party | Status |
|---|---|---|---|
| High Court, TELANGANA | Arbitration matter | Filed by the company against M/S. Unimed Health Care Private Limited | Disposed |
To see the full case history of Cipher Oncology Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Cipher Oncology Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Group structure & subsidiaries
Cipher Oncology has 1 associated company. This group structure data is as of FY 2023. The table lists each entity with its relationship and holding.
1
Associated companies
Employees & EPFO
Cipher Oncology Private Limited has a workforce of 125 employees on its EPFO records as of May 2026, across 1 active EPFO establishment.
Employee count
125
Active EPFO establishments
1
Employee growth
15.7%
Headcount by financial year
| Financial year | Employees (EPFO) |
|---|---|
| FY 2026-27 | 125 |
| FY 2025-26 | |
| FY 2024-25 | |
| FY 2023-24 | |
| FY 2022-23 | |
| FY 2021-22 | |
| FY 2020-21 |
To see the full employee and EPFO history of Cipher Oncology Private Limited, buy the company report.
GST
Cipher Oncology has 2 GST registrations: 2 active.
Total GSTINs
2
Active
2
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36AAICC1561H1ZR | Telangana | Active | 18 Jul 2019 |
| 37AAICC1561H1ZP | Andhra Pradesh | Active | 09 Sep 2021 |
To see the full GST registrations and return filing status of Cipher Oncology Private Limited, buy the company report.
Recent activity
Cipher Oncology Private Limited has 5 board changes on record since 2019: 2 appointments and 3 cessations. The latest: Samba Sivaiah Kuraparthy ceased to be Additional Director on 06 May 2020.
AGM
Cipher Oncology Private Limited last Annual general meeting of members was held on 25 Sep 2025 as per latest MCA records.
Filing
Cipher Oncology Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Hyderabad.
Ceased
Samba Sivaiah Kuraparthy ceased to be Additional Director.
Ceased
Bhojaraj Rohit Manipal ceased to be Director.
Ceased
Sonali Pradeep Srungaram ceased to be Director.
Appointed
Sasi Kiran Sunkara was appointed as Director.
Appointed
Sonali Pradeep Srungaram was appointed as Managing Director.
Incorporation
30 Apr 2019
Cipher Oncology Private Limited was registered on 30 Apr 2019 with Roc Hyderabad & aged 7 years 6 months as per MCA records.
Frequently asked questions
Cipher Oncology is an active private limited company based in Hyderabad, Telangana, India. The company works in oncology clinics and cancer treatment, within the healthcare industry. It was incorporated on 30 April 2019 (7+ years old) and is registered under CIN U85100TG2019PTC132422.
Cipher Oncology has 2 current directors:
- Sonali Pradeep Srungaram - Managing Director
- Sasi Kiran Sunkara - Director
The latest financial statements of Cipher Oncology on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 25 September 2025. Year-wise statements from FY 2020 are in the company report.
The GSTIN of Cipher Oncology is 36AAICC1561H1ZR, registered in Telangana. The company has 2 GST registrations in all, of which 2 are active. Other active GSTINs include 37AAICC1561H1ZP (Andhra Pradesh).
The CIN (Corporate Identification Number) of Cipher Oncology is U85100TG2019PTC132422. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Cipher Oncology has 2 court cases on record: 2 filed by the company.
Cipher Oncology was incorporated on 30 April 2019, making it 7+ years old. It is registered with the Registrar of Companies, Hyderabad.
Cipher Oncology has 11 deals on record (7 funding rounds, 4 secondary share transfers), with disclosed funding of ₹94.43 Cr; the latest was in September 2025.
The peers of Cipher Oncology by revenue are Malnad Hospital and Institute of Oncology Private Limited, Kakatiya Institute of Oncology Private Limited, Karunadu Oncology Haematology Associates Private Limited, Erode Cancer Centre Private Limited, Bridge Gap Lifesciences Private Limited, all in the Healthcare industry (Oncology Care), with the same principal business activity (hospital activities).
Samba Sivaiah Kuraparthy ceased to be Additional Director on 06 May 2020. Bhojaraj Rohit Manipal ceased to be Director on 22 Jan 2020. Sonali Pradeep Srungaram ceased to be Director on 01 May 2019. Cipher Oncology has 5 board changes on record in total.
Yes, Cipher Oncology is recognised as a startup by the Department for Promotion of Industry and Internal Trade (DPIIT).
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages